by Felicia Lenzo | Nov 30, 2016 | News
Dr. Lucio Miele from LSU School of Medicine talks about the benefits of the recent partnership with OmniSeq on WVUE FOX 8 News in New...
by Felicia Lenzo | Nov 10, 2016 | News
NEW ORLEANS, LOUISANA – November 10, 2016 – Louisiana State University Health Sciences Center New Orleans ( LSU Health New Orleans) and Omniseq (OmniSeq®), a subsidiary of the Roswell Park Cancer Institute (RPCI), are now partnering to provide oncologists with...
by Felicia Lenzo | Nov 10, 2016 | News
THERMO FISHER SCIENTIFIC (TMO) EXPANDS PORTFOLIO OF NEXT-GENERATION SEQUENCING CANCER RESEARCH ASSAYS New Oncomine products enable immune response analysis of the tumor microenvironment, interrogation of BRCA 1-2 genes, and liquid biopsy research using cell-free DNA...
by Felicia Lenzo | May 29, 2016 | News
BUFFALO, N.Y., March 31, 2016 /PRNewswire/ — OmniSeq LLC today announced the appointment of biotech industry veteran Mark Gardner as CEO and member of its Board of Directors. His role will be effective in April after he transitions from his executive management post...
by Felicia Lenzo | Sep 10, 2015 | News
OmniSeq℠ Aims to Change the Landscape of Cancer Treatment Through Unparalleled Diagnostic Precision, Therapeutic Knowledge and Peer-to-Peer Collaboration Buffalo, NY – June 11, 2015 – OmniSeq, LLC today announced that it has officially begun its spin out from Roswell...
